Nighttime Glucose Variation in Type 2 Diabetes with HbA1c 8%
For a patient with type 2 diabetes, HbA1c 8%, on metformin 1000 mg twice daily and bedtime insulin glargine 20 units, expect bedtime glucose around 153-177 mg/dL, with a nadir between 1:00-4:00 AM, and fasting glucose around 152-167 mg/dL. 1
Expected Nighttime Glucose Profile Table
| Time Period | Expected Glucose Range (mg/dL) | Clinical Notes |
|---|---|---|
| Bedtime (23:00) | 153-177 mg/dL | Target bedtime glucose for HbA1c 7.0-7.99% [1] |
| Early Night (23:00-01:00) | Gradual decline | Period of highest risk for early hypoglycemia if bedtime glucose <153 mg/dL [2] |
| Overnight Nadir (01:00-04:00) | Lowest glucose values | Minimal hypoglycemia risk with glargine; stable insulin action [3] |
| Early Morning (04:00-07:30) | Gradual rise toward fasting | Dawn phenomenon may cause rise; second hypoglycemia risk window [2] |
| Fasting/Pre-breakfast (07:00-08:00) | 152-167 mg/dL | Target fasting glucose for HbA1c 7.5-7.99% [1] |
Key Clinical Context
Baseline Glycemic Expectations
- With HbA1c 8%, the average fasting glucose should be approximately 167 mg/dL (157-177 mg/dL) to correlate with this level of glycemic control 1
- Bedtime glucose targets should be around 177 mg/dL (166-188 mg/dL) for patients at this HbA1c level 1
- The current regimen (metformin + 20 units glargine) is likely underdosed, as typical basal insulin requirements range from 39-70 units daily in similar populations 3, 4
Nocturnal Glucose Pattern Characteristics
Insulin glargine provides relatively flat overnight coverage compared to NPH insulin, with maximum glucose lowering occurring just prior to the next injection regardless of timing 3
Two critical hypoglycemia risk windows exist: 2
- Early night (23:00-01:00): Risk predicted by bedtime glucose <153 mg/dL
- Early morning (04:00-07:30): Risk indicated by fasting glucose <5.5 mmol/L (99 mg/dL)
- Minimal risk period (01:00-04:00): Lowest hypoglycemia occurrence
Treatment Optimization Considerations
The combination of metformin with basal insulin glargine reduces insulin requirements by approximately 17% compared to insulin alone while improving HbA1c by an additional 0.74% 5
For this patient at HbA1c 8%, insulin dose titration is clearly needed: 6
- Current dose: 20 units
- Expected requirement: 39-70 units based on clinical trial data 3
- Titration algorithm: Increase by 2 units every 3 days targeting fasting glucose 80-130 mg/dL 6
Common Pitfalls to Avoid
Bedtime glucose monitoring is more reliable than 3:00 AM testing for preventing nocturnal hypoglycemia 2
- Bedtime glucose >153 mg/dL prevents early-night hypoglycemia
- Fasting glucose >99 mg/dL indicates absence of early-morning hypoglycemia
Symptomatic hypoglycemia is most common during the first 12 weeks of insulin initiation (4.1 episodes/patient-year with glargine + metformin), then decreases significantly 4
Pre-dinner hyperglycemia (glucose 8.6-10.1 mmol/L or 155-182 mg/dL) commonly persists with bedtime basal insulin alone, indicating need for additional prandial coverage or GLP-1 RA if HbA1c remains above goal 4